David Reeder
Known title: DirectorCIK: 0001597133
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Chewy vet care growth offsets Mizuho price target cut. Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.
Transaction History
| ENTG | ▼ Sell | Tax Withholding | 5,386 | $809K | 8/18/2026 | View on chart |
| ENTG | ▲ Buy | Grant | 38,750 | $0 | 4/1/2026 | View on chart |
| ENTG | ▼ Sell | Other | 2,897 | $0 | 8/21/2025 | View on chart |
| ENTG | ▲ Buy | Grant | 56,624 | $0 | 8/18/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 11,582 | $422K | 5/5/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 7,863 | $287K | 5/2/2025 | View on chart |
| ENTG | ▲ Buy | Grant | 2,897 | $0 | 4/23/2025 | View on chart |
| CHWY | ▲ Buy | Grant | 152,261 | $0 | 4/8/2025 | View on chart |
| CHWY | ▲ Buy | Grant | 397,556 | $0 | 3/26/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 262,433 | $9.8M | 2/7/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 45,125 | $1.7M | 2/7/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 53,571 | $2.0M | 2/6/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 54,022 | $2.0M | 2/5/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 53,931 | $2.0M | 2/4/2025 | View on chart |
| CHWY | ▼ Sell | Open Market | 53,834 | $2.1M | 2/3/2025 | View on chart |
| ENTG | ▲ Buy | Grant | 1,643 | $0 | 4/24/2024 | View on chart |
| CHWY | ▲ Buy | Grant | 991,392 | $0 | 4/4/2024 | View on chart |
| CHWY | ▲ Buy | Grant | 311,125 | $0 | 4/4/2024 | View on chart |
| ENTG | ▲ Buy | Grant | 190 | $0 | 3/7/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Entegris Shares Gain After Analysts Adopt More Constructive View
Analysts have shifted to a more positive outlook on Entegris, lifting its fair‑value estimate modestly. The stock, however, fell along with other semiconductor names such as Micron and AMD, reflecting broader sector weakness. The lift comes amid a broader rebound in the semiconductor sector after a recent dip, but the price remains below the 200‑day moving average.
Entegris Shares Gain After Analysts Adopt More Constructive View. Analysts have shifted to a more positive outlook on Entegris, lifting its fair‑value estimate modestly. The stock, however, fell along with other semiconductor names such as Micron and AMD, reflecting broader sector weakness. The lift comes amid a broader rebound in the semiconductor sector after a recent dip, but the price remains below the 200‑day moving average.